1-3 of 3
Desire Collen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.

Peter Verhamme, MD, PhD, Steve Pakola, MD, Marc Jacquemin, MD, PhD, Jean Marie Saint-Remy, MD, PhD, Jean Marie Stassen, PhD, Desire Collen, MD, PhD, Rikke Riisbro, MD, PhD, Thomas Jensen, MD, PhD, Steven Glazer, MD
Journal: Blood
Blood (2007) 110 (11): 312.
https://doi.org/10.1182/blood.V110.11.312.312
Published: 2007
Journal Articles

Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization.

Marc Tjwa, MD, PhD, Lieve Moons, PhD, Koen Theunissen, MD, Rute Moura, MSc, PhD, Francesco Blasi, MD, PhD, Mieke Dewerchin, PhD, Nicolai Sidenius, PhD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 472.
https://doi.org/10.1182/blood.V106.11.472.472
Published: 2005
Journal Articles

Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications.

Marc Tjwa, MD, Nicolai Sidenius, PhD, Koen Theunissen, MD, Rute Moura, MSc, Lieve Moons, PhD, Stefan Janssens, MD, PhD, Francesco Blasi, MD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 117.
https://doi.org/10.1182/blood.V104.11.117.117
Published: 2004